Vivos receives FDA 510(k) clearance for oral devices to treat severe sleep apnea

The clearance positions the company to offer an alternative to continuous positive airway pressure devices and neurostimulation implants.

By Nick Paul Taylor • Nov. 30, 2023

GE HealthCare gets 510(k) clearance for algorithm to detect collapsed lungs

The system provides immediate notifications to support the triaging of emergency room patients.

By Nick Paul Taylor • Nov. 29, 2023

Explore the Trendline➔

Medical device industry continues to turn to AI

While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

By MedTech Dive staff

Unomedical recall of infusion sets tagged as Class I by FDA

The company notified Tandem Diabetes Care, its sole consignee, in October of the risk for infusion sets to detach from insulin pumps, disrupting insulin delivery.

By Nick Paul Taylor • Nov. 28, 2023

Why medical device companies are worried about the EPA’s planned sterilization regs

The EPA is expected to finalize new regulations in March that would limit ethylene oxide emissions from companies that sterilize medical devices.

By Elise Reuter , Shaun Lucas • Nov. 27, 2023

FDA withdraws from Global Harmonization Working Party

The agency has become “concerned with the divergent harmonization efforts for medical devices” and will focus on working with the International Medical Device Regulators Forum going forward.

By Elise Reuter • Nov. 27, 2023

FDA weighs in on SoClean’s field correction for CPAP cleaning machines

SoClean announced a voluntary field action last week to address user complaints related to improper set-up and unauthorized modifications.

By Nick Paul Taylor • Nov. 22, 2023

Medtronic wins pulsed field ablation CE mark, teeing up 2-front challenge to Boston Scientific

Medtronic received the mark for its single-shot PFA device, clearing the company to expand its portfolio of European atrial fibrillation devices.

By Nick Paul Taylor • Nov. 22, 2023

FDA concerned Cardinal Health failed to mitigate risk of incompatible syringes

Days after posting the Class 1 recall notice, the FDA said changes made to certain syringes could lead to overdose, underdose, or delays in therapy or alarms.

By Nick Paul Taylor • Nov. 21, 2023

B. Braun infusion pump safety correction linked to 51 complaints, one death

While no devices need to be removed, the FDA labeled the correction a Class I recall due to the risk of injury or death for patients.

By Nick Paul Taylor • Nov. 20, 2023

FDA acts on industry call for clarity about scope of device shortage reporting rules

The agency posted a final guidance and draft guidance on medical device shortage reporting requirements, addressing industry concerns.

By Nick Paul Taylor • Nov. 17, 2023

Abbott Diabetes Care CMO Mahmood Kazemi on expanding CGM access

Kazemi hopes anyone with diabetes will be able to access the technology, even people who don’t take insulin.

By Elise Reuter • Nov. 17, 2023

Top FDA official Woodcock to retire early next year

The 37-year veteran helmed the agency’s pandemic response, and was a key decision-maker in controversial calls on opioids, an Alzheimer's therapy and muscular dystrophy drugs.

By Jonathan Gardner • Nov. 17, 2023

FDA seeks feedback on racial bias of pulse oximeters, convenes advisory committee

The agency published a paper on improving the evaluation of pulse oximeters to take skin pigmentation into account.

By Nick Paul Taylor • Nov. 17, 2023

LetsGetChecked secures first FDA authorization for at-home chlamydia and gonorrhea test

Jeff Shuren, director of the Center for Devices and Radiological Health, said the test will give patients “more information about their health from the privacy of their own home.”

By Nick Paul Taylor • Nov. 16, 2023

Congress delays Medicare lab payment cuts for one year

The American Clinical Laboratory Association said it remains focused on getting legislation passed that would mitigate pending Medicare payment reductions.

By Susan Kelly • Nov. 16, 2023

FDA-ordered report tackles how to manage cybersecurity risks of legacy devices

The report from MITRE proposes multiple actions for protecting older medical devices, including research into more modular devices and collecting data on cyber risks.

By Nick Paul Taylor • Nov. 16, 2023

Cardinal’s changes to disposable syringes trigger FDA Class I recall notice

The problem is linked to 15 reports of delayed therapy and 13 reports of inaccurate dispensing.

By Nick Paul Taylor • Nov. 15, 2023

Biden initiative aims to accelerate women’s health research

AdvaMed endorsed the White House effort, stressing the need for equitable development and funding of new technologies.

By Susan Kelly • Nov. 14, 2023

Olympus receives Class I recall label for another bronchoscope safety issue

The company's latest corrective action follows four reports of “endobronchial combustion” during procedures with its bronchoscopes.

By Ricky Zipp • Updated Dec. 21, 2023

FDA warns providers about using surgical mesh for breast surgery after BD label update

The regulator reminded providers that there are “no surgical mesh products cleared or approved by the FDA for use in breast surgery.”

By Nick Paul Taylor • Nov. 13, 2023

Acon receives first FDA clearance for over-the-counter COVID-19 antigen test

The FDA is encouraging manufacturers to transition to traditional review pathways now that the acute phase of the COVID-19 crisis is over.

By Nick Paul Taylor • Nov. 10, 2023

NICE backs use of hybrid closed loop systems for Type 1 diabetes, if companies offer discounts

The group’s recommendation gives around 150,000 people with Type 1 diabetes living in England the chance to access the systems, according to an NHS England official.

By Nick Paul Taylor • Nov. 9, 2023

FTC challenges patents held by nine big drugmakers, citing unfair competition

The agency claims intellectual property for emergency allergy shot EpiPen and asthma medication Advair was “improperly listed” in an FDA database.

By Jonathan Gardner • Nov. 8, 2023

25 attorneys general urge FDA to act fast to mitigate risk of racial bias in pulse oximetry

The AGs want the FDA to “require manufacturers and vendors of pulse oximeters to include clear, comprehensible and evidence-based warning labels.”

By Nick Paul Taylor • Nov. 7, 2023

FDA extends pandemic-era policy allowing certain device, production changes without prior approval

Companies can make limited modifications on certain devices and manufacturing processes to address supply shortages or production limitations.

By Ricky Zipp • Nov. 2, 2023